These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25792143)

  • 1. Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.
    Inami H; Shishikura J; Yasunaga T; Ohno K; Yamashita H; Kato K; Sakamoto S
    Bioorg Med Chem; 2015 Apr; 23(8):1788-99. PubMed ID: 25792143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.
    Inami H; Shishikura JI; Yasunaga T; Hirano M; Kimura T; Yamashita H; Ohno K; Sakamoto S
    Chem Pharm Bull (Tokyo); 2019; 67(7):699-706. PubMed ID: 31257325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats.
    Yamashita H; Ohno K; Amada Y; Hattori H; Ozawa-Funatsu Y; Toya T; Inami H; Shishikura J; Sakamoto S; Okada M; Yamaguchi T
    J Pharmacol Exp Ther; 2004 Jan; 308(1):127-33. PubMed ID: 14569061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of YM928, a novel moncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist.
    Ohno K; Tsutsumi R; Matsumoto N; Yamashita H; Amada Y; Shishikura J; Yatsugi HI; Okada M; Sakamoto S; Yamaguchi T
    J Pharmacol Exp Ther; 2003 Jul; 306(1):66-72. PubMed ID: 12660313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats.
    Yamashita H; Ohno K; Amada Y; Inami H; Shishikura J; Sakamoto S; Okada M; Yamaguchi T
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):99-105. PubMed ID: 15322731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
    Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
    J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters.
    Micale N; Zappalà M; Grasso S; Puja G; De Sarro G; Ferreri G; De Sarro A; Toma L; De Micheli C
    J Med Chem; 2002 Sep; 45(20):4433-42. PubMed ID: 12238923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
    Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V
    J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
    Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG
    J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones.
    Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puja G; Baraldi M; De Micheli C
    J Med Chem; 2000 Jul; 43(15):2851-9. PubMed ID: 10956193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 7,8-(methylenedioxy)-1-phenyl-3,5-dihydro-4H-2, 3-benzodiazepin-4-ones as novel and potent noncompetitive AMPA receptor antagonists.
    Wang Y; Konkoy CS; Ilyin VI; Vanover KE; Carter RB; Weber E; Keana JF; Woodward RM; Cai SX
    J Med Chem; 1998 Jul; 41(14):2621-5. PubMed ID: 9651166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.
    Micale N; Colleoni S; Postorino G; Pellicanò A; Zappalà M; Lazzaro J; Diana V; Cagnotto A; Mennini T; Grasso S
    Bioorg Med Chem; 2008 Mar; 16(5):2200-11. PubMed ID: 18083036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, chiral resolution, and enantiopharmacology of a potent 2,3-benzodiazepine derivative as noncompetitive AMPA receptor antagonist.
    Zappalà M; Postorino G; Micale N; Caccamese S; Parrinello N; Grazioso G; Roda G; Menniti FS; De Sarro G; Grasso S
    J Med Chem; 2006 Jan; 49(2):575-81. PubMed ID: 16420043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonists: synthesis and structure-activity relationships of 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and related compounds.
    Ohmori J; Kubota H; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1996 Mar; 39(6):1331-8. PubMed ID: 8632440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity.
    Jain N; Jaiswal J; Pathak A; Singour PK
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):63-73. PubMed ID: 28056730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant and neurotoxicity evaluation of some novel kojic acids and allomaltol derivatives.
    Aytemir MD; Calis U
    Arch Pharm (Weinheim); 2010 Mar; 343(3):173-81. PubMed ID: 20108269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists.
    Gitto R; De Luca L; Pagano B; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
    Bioorg Med Chem; 2008 Mar; 16(5):2379-84. PubMed ID: 18077172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis of 6-substituted-pyrido[3,2-d]pyridazine derivatives with anticonvulsant activity.
    Dong ZQ; Liu XM; Wei CX; Quan ZS
    Med Chem; 2015; 11(6):595-601. PubMed ID: 25770755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.